Rainbow Childrens Medicare LtdNSE: RAINBOW
Open the Rainbow Childrens Medicare Ltd page
Follow Rainbow Childrens Medicare LtdFree account. Get a note when Rainbow Childrens Medicare Ltd files.
Q1 FY27 results analysis · July 31, 2026

Rainbow Childrens Medicare Ltd Q1 FY27 Results Analysis: Revenue Surges 33%, Margin Compresses 71 bps

+13.2%PAT year on year, Rs. 60.57 Cr
Cofacto ResearchPublished July 31, 20262 min readNeutral read
Quick summary

Rainbow Childrens Medicare Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 469.99 Cr (+33.17% YoY) and PAT growth of +13.22% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 469.99 Cr (+33.17% YoY)
PAT (Q1)Rs. 60.57 Cr (+13.22% YoY)
EBITDA margin28.65% (-71 bps YoY)
EPS (Q1)Rs. 5.97 (+13.28% YoY)
Market capRs. 15,444.22 Cr
CMPRs. 1,520.60

Quarter Snapshot

Consolidated revenue grew 33% YoY, powered by acquisitions that added Rs.41 Cr in revenue. However, EBITDA margin compressed 71 bps YoY and PAT-owners growth lagged revenue significantly, with standalone PAT nearly flat. New hospital expansions in Mumbai and Nellore provide future catalysts but near-term margin pressure persists.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 33.17% YoY to Rs.469.99 Cr, with organic standalone growth of 22.64%.
  • Subsidiary revenue contribution from acquisitions jumped from Rs.18.18 Cr to Rs.59.44 Cr, reflecting successful integration.
  • EBITDA grew 29.94% YoY to Rs.134.65 Cr.
  • EPS grew 13.28% YoY to Rs.5.97.

Risk Factors

  • EBITDA margin compressed 71 bps YoY to 28.65% and 248 bps QoQ, indicating cost pressure.
  • PAT-owners growth (13.22%) significantly lagged revenue growth (33.17%), reflecting margin erosion.
  • Standalone PAT grew only 1.91% YoY, showing organic profitability weakness.
  • Professional fees to doctors grew faster than revenue QoQ (+9.89% vs +2.19%), pressuring margins.
  • No FY27 forward guidance provided, reducing visibility on future trajectory.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.